Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00825487 | Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies | completed | Phase 1 | 50 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Oct 19, 2011 | clinicaltrials |
| NCT01141257 | Study of Angiocal® in Patients With Solid Tumors, Investigating Safety, Tolerability, Blood Concentration of Study Drug | completed | Phase 1 | 26 | Pieris Pharmaceuticals GmbHINDUSTRY |
| 1 |
| Oct 19, 2011 |
| clinicaltrials |
| NCT00785941 | A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available | completed | Phase 1 | 16 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT00513851 | Phase 1 Study of OSI-930 in Cancer Patients | completed | Phase 1 | 60 | Astellas Pharma IncINDUSTRY | 2 | Sep 27, 2011 | clinicaltrials |
| NCT00603356 | Phase I Study of OSI-930 and Erlotinib in Cancer Tumors | completed | Phase 1 | 60 | Astellas Pharma IncINDUSTRY | 2 | Sep 27, 2011 | clinicaltrials |
| NCT01210846 | A Cardiac Safety Study of Tivozanib to Evaluate the Electrocardiogram and Pharmacokinetic-Electrocardiogram Dynamics in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Sep 26, 2011 | clinicaltrials |
| NCT01253837 | L19TNFα in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT01062620 | A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer | completed | Phase 1 | 49 | Axelar ABINDUSTRY | 1 | Sep 15, 2011 | clinicaltrials |
| NCT01148628 | Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 54 | Southern Europe New Drug OrganizationOTHER | 2 | Sep 13, 2011 | clinicaltrials |
| NCT01155505 | Lenalidomide and Paclitaxel in Advanced Solid Tumors | unknown | Phase 1 | 28 | Southern Europe New Drug OrganizationOTHER | 2 | Sep 13, 2011 | clinicaltrials |
| NCT01159418 | LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors | unknown | Phase 1 | 36 | Southern Europe New Drug OrganizationOTHER | 1 | Sep 13, 2011 | clinicaltrials |
| NCT01299415 | Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor | terminated | Phase 1 | 17 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00882180 | Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement | completed | Phase 1 | 41 | Alnylam PharmaceuticalsINDUSTRY | 2 | Aug 24, 2011 | clinicaltrials |
| NCT00611468 | Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors | completed | Phase 1 | 29 | Accelerated Community Oncology Research NetworkOTHER | 1 | Aug 22, 2011 | clinicaltrials |
| NCT00982267 | A Trial Of SU14813 In Patients With Advanced Solid Malignancies | completed | Phase 1 | 77 | PfizerINDUSTRY | 2 | Aug 8, 2011 | clinicaltrials |
| NCT00003038 | Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00003690 | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00004075 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00005068 | Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00006362 | PS-341 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00502567 | A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors | completed | Phase 1 | 104 | AstraZenecaINDUSTRY | 1 | Jul 27, 2011 | clinicaltrials |
| NCT01114191 | A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869) | completed | Phase 1 | 12 | AbbottINDUSTRY | 1 | Jul 26, 2011 | clinicaltrials |
| NCT01386866 | Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid Tumors | completed | Phase 1 | 4 | AmgenINDUSTRY | 0 | Jul 15, 2011 | clinicaltrials |
| NCT00401180 | Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer | completed | Phase 1 | 25 | The Cleveland ClinicOTHER | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00415116 | Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 14 | The Cleveland ClinicOTHER | 0 | Jul 8, 2011 | clinicaltrials |
| NCT01151384 | Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors(LE-DT) | completed | Phase 1 | 30 | INSYS Therapeutics IncINDUSTRY | 1 | Jul 4, 2011 | clinicaltrials |
| NCT00112619 | Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors | terminated | Phase 1 | 19 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00768391 | Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available | completed | Phase 1 | 20 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00891280 | Dose-escalation Study of Oral CX-4945 | unknown | Phase 1 | 55 | Cylene PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00973076 | Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055 | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00658970 | Evaluation of KX2-391 in Patients With Advanced Malignancies | completed | Phase 1 | 50 | Athenex, Inc.INDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00788099 | Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 45 | PharmaMarINDUSTRY | 2 | Jun 7, 2011 | clinicaltrials |
| NCT00616213 | PR104 and G-CSF in Treating Patients With Solid Tumors | completed | Phase 1 | 5 | Proacta, IncorporatedINDUSTRY | 2 | Jun 1, 2011 | clinicaltrials |
| NCT01358227 | A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors | completed | Phase 1 | 26 | Proacta, IncorporatedINDUSTRY | 1 | May 24, 2011 | clinicaltrials |
| NCT00704366 | AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours | completed | Phase 1 | 18 | AstraZenecaINDUSTRY | 1 | May 16, 2011 | clinicaltrials |
| NCT01194193 | Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours | withdrawn | Phase 1 | 63 | AstraZenecaINDUSTRY | 0 | May 16, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00747734 | A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 35 | Genentech, Inc.INDUSTRY | 0 | Apr 20, 2011 | clinicaltrials |
| NCT00470405 | Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma | completed | Phase 1 | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 18, 2011 | clinicaltrials |
| NCT00148993 | Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors | withdrawn | Phase 1 / Phase 2 | 100 | Hadassah Medical OrganizationOTHER | 1 | Apr 8, 2011 | clinicaltrials |
| NCT00003144 | Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 44 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003331 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 30 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00004105 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00004030 | VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin | completed | Phase 1 / Phase 2 | 45 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00020748 | Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00750425 | Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours | completed | Phase 1 | 46 | AstraZenecaINDUSTRY | 2 | Mar 10, 2011 | clinicaltrials |
| NCT00003294 | Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer | completed | Phase 1 | 24 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00003882 | Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors | completed | Phase 1 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00024141 | Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Oct 19, 2011source: clinicaltrials